Sydney Cancer Partners aims to build translational cancer research capacity through funding, education and support programs to members.
Sydney Cancer Partners brings together over 700 cancer researchers and clinical teams from across the University of Sydney, 11 medical research institutes, 16 major public and private hospitals and health precincts in north, west and central Sydney and in rural and regional NSW.
Sydney Cancer Partners (SCP) was formed under the auspices of Sydney Health Partners (SHP) in 2021 following award of a Cancer Institute NSW Translational Cancer Research Capacity Building grant. In 2022 SCP was recognised as the Clinical Academic Group for Cancer by SHP. The goal of SCP is to foster a culture of innovative, collaborative research, embedded across the full spectrum of cancer care, with a clear aim of improving cancer outcomes. It brings together cancer researchers and clinical teams from across the University of Sydney, 11 affiliated medical research institutes, 16 major public and private hospitals and health precincts in north, west and central Sydney as well as in western, far western and northern NSW through the University of Sydney’s Rural Clinical School. SCP is committed to establishing an inclusive framework, and funding capacity building initiatives including Fellowships, PhD scholarships and pilot projects. We also work with colleagues from Maridulu Budyari Gumal (SPHERE) and NSW Regional Health Partners to ensure coordination of research efforts and provide state-wide education, including a monthly virtual seminar series and a state-wide cancer conference being held for the first time in 2022.
Provide relevant, unique and supportive programs and funding opportunities to drive translation of research into better health service delivery and cancer outcomes.